Navigation Links
Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults
Date:12/16/2008

Synvista Therapeutics Technology Provided CML Biomarker Data for Studies

MONTVALE, N.J., Dec. 16 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) today announced two publications demonstrating findings from studies that indicated that the presence of the advanced glycation end product (A.G.E.) called carboxymethyl-lysine (CML) in older adults is associated with a decline in renal function and arterial stiffness in older adults. Kits developed through a license to Synvista's technology were used in these studies. Synvista is validating this clinical diagnostic assay as it prepares to submit a CML kit for 510(k) clearance in the second half of 2009.

"These studies represent an important next step in our understanding of the role of CML in an elderly population, and they provide physicians more information that may be useful in the prevention of cardiovascular and renal disease, particularly in older adults," said Richard D. Semba, M.D., M.P.H, W. Richard Green Professor of Ophthalmology, The Johns Hopkins University School of Medicine and lead author of both studies. "As we have learned, the elevation of CML is preventable in many cases, as it can be mitigated by changes in diet. Therefore, to bring a clearer understanding of this A.G.E. to the forefront may help doctors better explain to their patients how to help prevent cardiovascular and renal complications."

In one study, published in a recent edition of American Journal of Hypertension, investigators measured 493 adult subjects participating in the Baltimore Longitudinal Study of Aging for their aortic pulse wave velocity (an index of aortic stiffness) and CML (using Synvista's proprietary technology). Results demonstrated that elevated levels of CML in these subjects corresponded to increased arterial stiffness, a known predictor of cardiovascular disease.

T
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis
2. Data Confirm Synvista Therapeutics Haptoglobin Diagnostic Test Kit Success in Rapidly Determining Cardiovascular Risk in Patients with Diabetes
3. Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
4. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
5. Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure
6. Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diabetes
7. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
8. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
9. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
10. Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
11. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...TY, Calif., Nov. 25 Abax...any manufacturing point-of-care blood analysis sys...n and chief executive officer, will present at the...on Wednesday, December 2, 2009 at 2:00 p.m. ET. Th...otel in New York City. ,, About Abaxis ,,...
(Date:11/25/2009)...EW YORK, Nov. 25 Reportlinker.com ...ilable in its catalogue: ,, Pain Management -...m/p0164220/Pain-Management---Global-Trends.html ,...rgence of pain management clinics, and the advent ...n the pain management market. Healthcare reforms a...
(Date:11/24/2009)... BETHESDA, Md., Nov. 24 /PRNewswire-Asia/ -- Chin... ), a leading independent American provider of Wes...e,s Republic of China, today,announced that the Co...nplugged" Health Care Conference, to be held Decem..., Management is currently scheduled to prese...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6Chindex International to Present at Piper Jaffray Health Care Conference 2Madzone Marketing LLC Taps TransMedia Group to Provide Publicity Lift to Knife and Forklift 28TM 29 53445 1Madzone Marketing LLC Taps TransMedia Group to Provide Publicity Lift to Knife and Forklift 28TM 29 53445 2Global Jatropha Hi Tech Agricultural Training Programme 28JWTP 29 13319 1Global Jatropha Hi Tech Agricultural Training Programme 28JWTP 29 13319 2Global Jatropha Hi Tech Agricultural Training Programme 28JWTP 29 13319 3Global Jatropha Hi Tech Agricultural Training Programme 28JWTP 29 13319 4OPAXIO 28TM 29 Combined with Alimta 28R 29 Well Tolerated in Dose Ranging Study of Patients with Advanced Non Small Cell Lung Cancer 4808 1OPAXIO 28TM 29 Combined with Alimta 28R 29 Well Tolerated in Dose Ranging Study of Patients with Advanced Non Small Cell Lung Cancer 4808 2OPAXIO 28TM 29 Combined with Alimta 28R 29 Well Tolerated in Dose Ranging Study of Patients with Advanced Non Small Cell Lung Cancer 4808 3
...gen Analyses Continue to Show Benefits of Hormone ...-, MAPLE GROVE, Minn., Sept. 25 Upsher-Smith Lab...acts featuring Divigel(R),(estradiol gel) 0.1% wer...y,s 19th Annual Meeting in Orlando, Florida. Divig...pproved by the FDA in June 2007. It,offers the low...
...ces Demonstrates Rapid and Significant Pain,Reduct...ta inc., the industry,leader in electronic patient...or global clinical research, today announced that ...o capture important secondary efficacy,endpoint da...AL study, a,Phase II clinical trial of its proprie...
Other Medicine Technology:New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes 2New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes 3New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes 4invivodata Captures Symptom Relief Data in Endometriosis Trial 2
(Date:11/27/2009)..., Multi-purpose bilingual.... Designed for use by the business community to ed...iety of subjects from Safety issues to Dinosuars t... Saint Louis, MO (PRWEB) November 27, ..., electronics or toys to keep them busy any hour o...
(Date:11/27/2009)..., Three new interactive a... Williams & Wilkins expand health sciences lea... Durham, NC (Vocus) November...ams & Wilkins (LWW), a division of Wolters Klu...ree new anatomy education apps on the App Store. C...
(Date:11/26/2009)..., , PRINCETON, N.J., Nov. 27 /PRNewswir... will almost double over the next 25 years and ann...o hit $336 billion, up from $113 billion today, ac... of Diabetes Care . The National Changing Diabe...sk, commissioned the analysis by a team from the U...
(Date:11/26/2009)..., The copper sequestering drug tetrathiomolybdate... the treatment of Wilson disease, a disease caused...cancers. That much is known. Very little, however,...r level. , A new study led by Northwestern Unive...lue: the three-dimensional structure of TM bound t...
(Date:11/26/2009)... Fans get a bigger thrill when on an emotional rol...v. 26 (HealthDay News) -- Call it the fear factor ...ggests that spectators -- especially those who roo...faction if it,s a closely contested match and vict...even despair. , Chew on that this Thanksgiving ...
Breaking Medicine News(10 mins):Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3
... 2008 The James Redford,Institute for Transplant ...d to educating the public about the need for organ...ion site CharityFolks.com are,auctioning an EXCLUS...udios is an Academy Award (R)-winning computer,ani...
... 4, 2008 The Pacific,Heart, Lung & Blood Institut...containing products and adequate funding for resea...tee on Energy and Commerce,s,draft bill, currently...il, We support the committee print,s ban on all a...
... 2008 QED International Associates,Inc., administ...f 20,underlying indexes for the HealthShares(TM) E...ve at the opening of trading on Monday April 7, 20...g acquired by Bayer AG (NYSE: BAY )., Previously...
...ides with 2008 National Public Health Week, April,...airman Edward J. Markey (D-Mass.) and Congresswoma...mmittee on Energy Independence and Global,Warming ...ing., The announcement coincides with next week,s...
...ll Put Home Medical Equipment Providers out of,Bus... Million Seniors and,Disabled People in Kansas Cit...care,bidding program for durable medical equipment...ll likely disrupt,services for many of the 225,000...
...ions cut no-show rates 30%, study finds , ...ies make the case that more personal guidance and ...w-income and minority patients getting recommended...safety net" health-care systems serving urban popu...
Other Medicine News:Health News:Charityfolks.com and James Redford Institute Join to Raise Money for Organ Donation Awareness 2Health News:Pacific Heart, Lung & Blood Institute Position on Ban Asbestos Legislation 2Health News:Pacific Heart, Lung & Blood Institute Position on Ban Asbestos Legislation 3Health News:Medicare Bidding Program in Kansas City is Plagued by Problems, Says American Association for Homecare 2Health News:Medicare Bidding Program in Kansas City is Plagued by Problems, Says American Association for Homecare 3Health News:Patient Navigators Boost Colon Screens in Urban Minorities 2
Physiological Stress Loaded (P.S.L.) Stem
S-ROM Femoral Stems - Long Length Stems 36mm Neck with 21mm Calcar Replacement + Lat Neck
WG-1-10xx Revision Quatroloc Femoral Stems
AcuMatch C-Series LONG STEM
Medicine Products: